| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16729-078-01 | 16729-078 | HUMAN PRESCRIPTION DRUG | CARBIDOPA AND LEVODOPA | Carbidopa and Levodopa | TABLET, EXTENDED RELEASE | ORAL | 20130613 | N/A | ANDA | ANDA202323 | Accord Healthcare, Inc. | CARBIDOPA; LEVODOPA | 25 mg/1; 100 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-078-01) |
| 16729-078-17 | 16729-078 | HUMAN PRESCRIPTION DRUG | CARBIDOPA AND LEVODOPA | Carbidopa and Levodopa | TABLET, EXTENDED RELEASE | ORAL | 20131031 | N/A | ANDA | ANDA202323 | Accord Healthcare, Inc. | CARBIDOPA; LEVODOPA | 25 mg/1; 100 mg/1 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-078-17) |
| 16729-079-01 | 16729-079 | HUMAN PRESCRIPTION DRUG | CARBIDOPA AND LEVODOPA | Carbidopa and Levodopa | TABLET, EXTENDED RELEASE | ORAL | 20130613 | N/A | ANDA | ANDA202323 | Accord Healthcare, Inc. | CARBIDOPA; LEVODOPA | 50 mg/1; 200 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-01) |
| 16729-079-17 | 16729-079 | HUMAN PRESCRIPTION DRUG | CARBIDOPA AND LEVODOPA | Carbidopa and Levodopa | TABLET, EXTENDED RELEASE | ORAL | 20131115 | N/A | ANDA | ANDA202323 | Accord Healthcare, Inc. | CARBIDOPA; LEVODOPA | 50 mg/1; 200 mg/1 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-17) |